Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism
Over 80% of multiple-tested siRNAs and shRNAs targeting CD95 or CD95 ligand (CD95L) induce a form of cell death characterized by simultaneous activation of multiple cell death pathways preferentially killing transformed and cancer stem cells. We now show these si/shRNAs kill cancer cells through can...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-10-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/29702 |